Abstract
Background and objective: Idiopathic pulmonary fibrosis (IPF) is a heterogenous disease with a median survival of 3–4 years. Patients with mutations in telomere-related genes exhibit extrapulmonary signs and symptoms. These patients represent a distinct phenotype of IPF with worse survival. As genetic analyses are not available for most patients with
... read more